Latest Breaking News On - Janssen pharmaceutical companies - Page 9 : comparemela.com

Nasal Spray Shows Promise in Major Depression Treatment

A recent study demonstrated that esketamine nasal spray, used in conjunction with standard antidepressants, could significantly improve outcomes in patients with treatment-resistant depression.

HIV vaccine trial in Africa ends after data shows it wouldn't work

An experimental HIV vaccine trial that took place in Uganda, Tanzania and South Africa was halted after preliminary data suggested it wasn't effective.

Johnson & Johnson Vs. Pfizer: Better Pharma Stock? (NYSE:JNJ)

Janssen submits application to EMA for amivantamab-based lung cancer regimen in new indication

Today, the Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a type II extension of indication application to the European Medicines Agency (EMA) seeking approval of RYBREVANT®▼ (amivantamab) in combination with chemotherapy for the treatment of adult patients with advanced no.

FDA Approval Sought for Amivantamab Plus Chemo in EGFR+ Advanced NSCLC Following Osimertinib Progression

A supplemental biologics license application seeking the approval of amivantamab in combination with platinum-based chemotherapy for the treatment of patients with locally advanced or metastatic non–small cell lung cancer harboring EGFR exon 19 deletions has been submitted to the FDA.